Drug Type Small molecule drug |
Synonyms 3-caffeoylquinic-acid, 3-O-caffeoylquinic-acid, Coffee tannic acid + [1] |
Target |
Mechanism LAG3 inhibitors(Lymphocyte activation gene 3 protein inhibitors) |
Therapeutic Areas |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Molecular FormulaC16H18O9 |
InChIKeyCWVRJTMFETXNAD-NCZKRNLISA-N |
CAS Registry327-97-9 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | Chlorogenic acid | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Glioblastoma | Phase 3 | CN | 27 Nov 2018 | |
Glioblastoma Multiforme | Phase 3 | CN | 27 Nov 2018 | |
Small Cell Lung Cancer | Phase 2 | CN | 15 Nov 2018 | |
Lung Cancer | Phase 2 | CN | 17 Jul 2018 | |
Non-Small Cell Lung Cancer | Phase 2 | CN | 05 Jul 2018 | |
Advanced Lung Adenocarcinoma | Phase 1 | CN | 12 Sep 2018 | |
Advanced Lung Small Cell Carcinoma | Phase 1 | CN | 12 Sep 2018 | |
Advanced Lung Squamous Cell Carcinoma | Phase 1 | CN | 12 Sep 2018 | |
Kidney Neoplasms | Phase 1 | CN | 24 Oct 2014 | |
Liver Cancer | Phase 1 | CN | 24 Oct 2014 |
Phase 2 | 30 | Placebo (Placebo) | qsrofdqzba(simmgkrueq) = wtcyylbclk eyjedjjkly (cjtldwyayx, abtgfcvkky - tjkdiubjwp) View more | - | 02 Aug 2019 | ||
(Chlorogenic Acid) | qsrofdqzba(simmgkrueq) = fyjgtlkuyh eyjedjjkly (cjtldwyayx, yklamvawmw - phbqftpaqu) View more |